FDA Clears sNDA for Taletrectinib With Updated DOR Data in ROS1+ NSCLC - OncLive

<a href="https://news.google.com/rss/articles/CBMinwFBVV95cUxNNHFjcVF0R1dxWUJXNV…; target="_blank">FDA Clears sNDA for Taletrectinib With Updated DOR Data in ROS1+ NSCLC</a>&nbsp;&nbsp;<font color="#6f6f6f">OncLive</font>